Public-registry site landscape for NCT04722887, a Alpha1-Antitrypsin Deficiency study sponsored by Grifols Therapeutics LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04722887 (registry record) |
| Sponsor | Grifols Therapeutics LLC |
| Condition(s) | Alpha1-Antitrypsin Deficiency |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 5 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04722887 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →